课题基金 / 基金详情

Potential of primary care of multiple organ failure by gene analyses of characteristics of enterotoxin and endotoxin production in mixed infection of MTRSA and E. coli and fundamental examination

Potential of primary care of multiple organ failure by gene analyses of characteristics of enterotoxin and endotoxin production in mixed infection of MTRSA and E. coli and fundamental examination
MTRSA和大肠杆菌混合感染肠毒素和内毒素产生特征的基因分析及基础检查对多器官功能衰竭初级保健的潜力
批准号:
14571237
负责人:
SUMIYAMA Y
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2005

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们用MRSA在小鼠身上制造了肠道源性败血症。细菌悬浮液在第1天和第3天口服。为了帮助MRSA的定植,在第1天至第3天每天皮下注射氨苄西林(ABPC)来干扰小鼠的正常肠道菌群。细菌给药后,小鼠于第1、4、7天腹腔注射250 mg/kg环磷酰胺(CY)。我们研究了抗tsst -1单克隆抗体对MRSA肠道源性脓毒症的疗效。抗tsst -1单克隆抗体给药组虽无明显差异,但生存率较高。我们还学习了宿主防御。WT小鼠,IL-1 KO和IFN-γ KO小鼠用于MRSA肠道源性败血症。WT小鼠存活率超过80%,IL-1 KO小鼠全部死亡。IL-1 KO小鼠脏器内活菌数量显著增高。IFN-γ KO小鼠比WT小鼠更容易死亡。IL-1和IFN-γ是重要的宿主防御因子之一。
英文摘要
We made gut-derived sepsis with MRSA in mice. The bacterial suspension was orally administered between days 1 and 3. To aid the colonization of MRSA, the normal intestinal flora of the mice was disturbed by administering ampicillin (ABPC) by subcutaneous injection daily between days 1 and 3. After the administration of bacteria, mice were then given 250 mg/kg of cyclophosphamide (CY) by intraperitoneal injection on day 1, 4 and 7.We studied the efficacy of antiTSST-1 monoclonal antibody against gut-derived sepsis with MRSA.Although the significant difference was not recognized, antiTSST-1 monoclonal antibody administrated group tended to show highly survival rate.We also studied about host defense. WT mice, IL-1 KO and IFN-γ KO mice were used in gut-derived sepsis with MRSA. Although WT mice were survived more than 80%, IL-1 KO mice died all. The numbers of viable bacteria in organs were significantly high level in the IL-1 KO mice.IFN-γ KO mice were tend to die than WT mice.IL-1 and IFN-γ were indicated that they were one of important host defense cytokines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
脓毒症血浆胞外囊泡(Sepsis-EVs)通过S100A8/A9-RAGE-EEA1通路诱导急性肺损伤的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    夏杰
  • 依托单位:
miR-802靶向SDC4炎症反应信号通路调控sepsis相关性ALI的作用和机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    朱志鹏
  • 依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
  • 批准号:
    82371770
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    宁铂涛
  • 依托单位:
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    江继宏
  • 依托单位: